Precision Exercise in Children With Malignant Hemopathies
Launched by UNIVERSITY OF MILANO BICOCCA · Sep 11, 2019
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The "Precision Exercise in Children With Malignant Hemopathies" clinical trial is exploring how structured physical activity, guided by sports doctors and pediatric hematologists, can help children and young people with blood cancers like leukemia and lymphoma. This research is important because many of these patients spend long periods in the hospital and may not get enough exercise, which can lead to health problems later in life. The goal is to show that engaging in tailored exercise can support their recovery and help them reintegrate into their communities, including school and sports, once they are better.
To participate in this study, children aged 2 to 18 with malignant blood disorders who are receiving treatment at the Maria Letizia Verga Center are eligible. Unfortunately, younger children under 2 cannot join. Participants can expect to take part in supervised exercise sessions designed to improve their physical health and overall well-being during their treatment journey. This trial aims to highlight the importance of staying active, even during challenging times, and to help young patients lead healthier lives after their treatment concludes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with malignant hemopathies attending the Maria Letizia Verga Center
- Exclusion Criteria:
- • Children under 2 years
About University Of Milano Bicocca
The University of Milano-Bicocca is a distinguished academic institution renowned for its commitment to advancing research and education in the biomedical sciences. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials that aim to enhance patient care and medical outcomes. Its research initiatives are supported by state-of-the-art facilities and a dedicated team of experts, positioning the University of Milano-Bicocca as a leading sponsor in the realm of clinical trials, dedicated to translating scientific discoveries into practical applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Monza, Mb, Italy
Patients applied
Trial Officials
Andrea Biondi, MD, PhD
Principal Investigator
University of Milano Bicocca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials